Literature DB >> 1087557

Inactivation of human thrombin in the presence of human alpha1-proteinase inhibitor.

N R Matheson, J Travis.   

Abstract

Both the clotting and esterase activities of thrombin are inhibited by alpha1-proteinase inhibitor (alpha1-antitrypsin). The inhibition is a time-and temperature-dependent reaction which is proportional to the molar ratio of thrombin to inhibitor. Both the active-site serine residue of thrombin and the reactive-site lysine residue of alpha1-proteinase inhibitor are involved. alpha1-Proteinase inhibitor forms a 1:1 complex with thrombin that is comparable with the complex formed with trypsin and other proteinases. Incubation of the inhibitor with excess of thrombin, however, results in inactivation of nearly all the enzyme, even though only as much complex is formed as alpha1-proteinase inhibitor present. A portion of the remaining thrombin apparently aggregates. These results suggest that the mechanism for inhibition of thrombin may not be exactly the same as for trypsin, which is inhibited only to the extent to which complex is formed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1087557      PMCID: PMC1164146          DOI: 10.1042/bj1590495

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  15 in total

1.  THE CRYSTALLIZATION AND PARTIAL CHARACTERIZATION OF PORCINE TRYPSIN.

Authors:  J TRAVIS; I E LIENER
Journal:  J Biol Chem       Date:  1965-05       Impact factor: 5.157

2.  A modified spectrophotometric determination of chymotrypsin, trypsin, and thrombin.

Authors:  B C HUMMEL
Journal:  Can J Biochem Physiol       Date:  1959-12

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Isolation and properties of human plasma alpha-1-proteinase inhibitor.

Authors:  R Pannell; D Johnson; J Travis
Journal:  Biochemistry       Date:  1974-12-17       Impact factor: 3.162

5.  The plasmin inhibitor of human plasma. IV. Its action on plasmin, trypsin, chymotrypsin, and thrombin.

Authors:  A Rimon; Y Shamash; B Shapiro
Journal:  J Biol Chem       Date:  1966-11-10       Impact factor: 5.157

6.  Simultaneous purification of bovine prothrombin and factor X. Activation of prothrombin by trypsin-activated factor X.

Authors:  S P Bajaj; K G Mann
Journal:  J Biol Chem       Date:  1973-11-25       Impact factor: 5.157

7.  Selective, reversible loss of elastolytic activity of elastase and subtilisin resulting from electrostatic changes due to maleylation.

Authors:  A Gertler
Journal:  Eur J Biochem       Date:  1971-11-11

8.  The use of maleic anhydride for the reversible blocking of amino groups in polypeptide chains.

Authors:  P J Butler; J I Harris; B S Hartley; R Lebeman
Journal:  Biochem J       Date:  1969-05       Impact factor: 3.857

9.  Human leukocyte granule elastase: rapid isolation and characterization.

Authors:  R J Baugh; J Travis
Journal:  Biochemistry       Date:  1976-02-24       Impact factor: 3.162

10.  A new assay for the measurement of total progressive antithrombin.

Authors:  J L Lane; P Bird; C R Rizza
Journal:  Br J Haematol       Date:  1975-05       Impact factor: 6.998

View more
  2 in total

1.  New Mechanisms of Bromelain in Alleviating Non-Alcoholic Fatty Liver Disease-Induced Deregulation of Blood Coagulation.

Authors:  Po-An Hu; Sz-Han Wang; Chia-Hui Chen; Bei-Chia Guo; Jenq-Wen Huang; Tzong-Shyuan Lee
Journal:  Nutrients       Date:  2022-06-01       Impact factor: 6.706

2.  Inactivation of alpha- and beta-thrombin by antithrombin-III, alpha 2-macroglobulin and alpha 1-proteinase inhibitor.

Authors:  R Machovich; A Borsodi; G Blaskó; S A Orakzai
Journal:  Biochem J       Date:  1977-11-01       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.